- POSITIVE
Annual Revenue Modern Diagnostic Research Mar-2026 Annual Revenue is Rs 84 Cr which is growth of 6.8% YoY.
- NEGATIVE
Annual Net Profit Modern Diagnostic Research Mar-2026 Annual Net Profit is Rs 5 Cr which is growth of -41.4% YoY.
Modern Diagnostic Research Live Share Price Today, Share Analysis and Chart
BSE 03 Nov, 2026 12:59 PM (IST)
Modern Diagnostic Research Stock Price Analysis
Day Price Range-3.6% 1 Day return | 54.1 (LTP) 54.154.1 LowHigh |
|---|---|
Week Price Range-5.8% 1 Week return | 54.1 (LTP) 54.161 LowHigh |
Month Price Range-24.8% 1 Month return | 54.1 (LTP) 54.172 LowHigh |
Modern Diagnostic Research annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history
| Indicator | Graph | CAGR 3 Yrs | CAGR 5 Yrs | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 |
|---|---|---|---|---|---|---|---|---|---|
14.1% | 2.3% | 84.1 | 78.8 | 68.7 | 56.6 | 60.6 | 75.1 | ||
Operating Exp. Ann. | 7.2% | 4.3% | 70.5 | 60 | 56.1 | 57.3 | 54.2 | 57 | |
Operating Profit Ann. | - | -7% | 12.6 | 18 | 11.1 | -1 | 6 | 18.1 | |
OPM Ann. % | - | -9% | 14.96% | 22.79% | 16.09% | -1.74% | 9.89% | 24.03% | |
7.7% | 4.8% | 78.2 | 66.1 | 61.8 | 62.6 | 59.4 | 61.8 | ||
EBITDA Ann. | - | -5.7% | 13.6 | 18.8 | 12.6 | -0.7 | 6.4 | 18.2 | |
EBITDA Ann. margin % | - | -7.7% | 16.18% | 23.88% | 18.34% | -1.17% | 10.50% | 24.20% | |
Interest Ann. | 19.7% | 4.8% | 2.4 | 1.9 | 1.8 | 1.4 | 1.6 | 1.9 | |
Depr. | 10.1% | 12.4% | 5.2 | 4.2 | 3.9 | 3.9 | 3.7 | 2.9 | |
PBT Ann. | - | -14.7% | 6 | 12.7 | 6.9 | -5.9 | 1.1 | 13.3 | |
Tax Ann. | - | -27.1% | 0.7 | 3.8 | 1.1 | -0.2 | 2.6 | 3.4 | |
- | -11.9% | 5.3 | 9 | 5.8 | -5.7 | -1.5 | 10 | ||
Net Profit Ann. | - | -11.9% | 5.3 | 9 | 5.8 | -5.7 | -1.5 | 10 | |
NPM Ann. % | - | -13.8% | 6.32% | 11.50% | 8.63% | -10.18% | -2.41% | 13.29% | |
EPS Adj. latest Ann. | - | -11.9% | 3.5 | 5.9 | 3.8 | -3.8 | -1 | 6.6 |
Modern Diagnostic Research Technical Analysis
Modern Diagnostic Research EMA & SMA
| 5 Day | 58.3 |
|---|---|
| 10 Day | 60.1 |
| 12 Day | 60.8 |
| 20 Day | 62.7 |
| 26 Day | 63.3 |
|---|---|
| 50 Day | 63.1 |
| 100 Day | 64.1 |
Modern Diagnostic Research Delivery And Volume
Modern Diagnostic Research Resistance and Support
| First Resistance | 56.2 |
|---|---|
| Second Resistance | 56.2 |
| Third Resistance | 56.3 |
| First Support | 56.1 |
|---|---|
| Second Support | 56.1 |
| Third Support | 56.1 |
| Day RSI | 35.3 |
|---|---|
| Day MACD | -2.6 |
| Day MFI | 39.9 |
| Day MACD Signal Line | -1.5 |
Modern Diagnostic Research Beta
| 1 Month | -0.1 |
|---|---|
| 1 Year | - |
| 3 Month | 0.1 |
|---|---|
| 3 Year | - |
Modern Diagnostic Research Price Change Analysis
Modern Diagnostic Research Deals - Insider, Bulk, Block and SAST
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| AFFLUENCE GEMS PRIVATELIMITED | Bulk | Purchase | 14 Jan 2026 | 87 | 78,400 | BSE |
| SPREAD X SECURITIES PRIVATE LIMITED | Bulk | Purchase | 13 Jan 2026 | 89.95 | 204,800 | BSE |
| SPREAD X SECURITIES PRIVATE LIMITED | Bulk | Sell | 13 Jan 2026 | 87.95 | 3,200 | BSE |
| JMP SECURITIES PVT LTD | Bulk | Purchase | 13 Jan 2026 | 88.01 | 3,200 | BSE |
| JMP SECURITIES PVT LTD | Bulk | Sell | 13 Jan 2026 | 89.70 | 107,200 | BSE |
| SRINIVASA VARA PRASAD YAGNAMURTHY CHENCHU (PIS) | Bulk | Purchase | 13 Jan 2026 | 87.95 | 96,000 | BSE |
| VORA FINANCIAL SERVICES PVT LTD | Bulk | Sell | 13 Jan 2026 | 89.29 | 184,000 | BSE |
| SRINIVASA VARA PRASAD YAGNAMURTHY CHENCHU (PIS) | Bulk | Purchase | 09 Jan 2026 | 94.90 | 91,200 | BSE |
| YASHASVI WEALTH MANAGEMENT LLP | Bulk | Sell | 09 Jan 2026 | 94.46 | 97,600 | BSE |
| SB OPPORTUNITIES FUND II | Bulk | Purchase | 07 Jan 2026 | 98.95 | 97,600 | BSE |
Modern Diagnostic Research Corporate Actions
Modern Diagnostic Research Board Meetings
Modern Diagnostic Research past and upcoming board meetings.
#Ex-Date | Purpose | Notes |
|---|---|---|
103 Sep 2026 | A.G.M. | - |
229 May 2026 | Audited Results | - |
313 May 2026 | Others | Inter-alia, to consider 1. RESOLUTION FOR EXTENTION OF TIME FOR UTILIZATION OF NET ISSUE PROCEEDS AND COMPLETION OF PROJECT AS STATED IN PROSPECTUS. 2. Other business matters. |
409 Mar 2026 | Others | Inter-alia, to consider 1. Approve change in equipment specification from SPECT to SPECT-CT at Sector 40, Gurugram. 2. Other business matters. |
Modern Diagnostic Research Corporate Filings
Modern Diagnostic Research BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.
| Date | Announcement Title | Details | Links |
|---|---|---|---|
| 13 Oct 2026 | Modern Diagnostic & Research Centre Ltd - 544673 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 | Certificate under Regulation 74(5) for the half year ended September 30, 2026 | |
| 01 Oct 2026 | Modern Diagnostic & Research Centre Ltd - 544673 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | Submission of voting results of the 14th AGM of Modern Diagnostic & Research Centre Limited held on Wednesday, 30th September, 2026 | |
| 01 Oct 2026 | Modern Diagnostic & Research Centre Ltd - 544673 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report | Submission of voting results of the 14th AGM of Modern Diagnostic & Research Centre Limited held on Wednesday, 30th September, 2026 | |
| 30 Sep 2026 | Modern Diagnostic & Research Centre Ltd - 544673 - Shareholder Meeting / Postal Ballot-Outcome of AGM | Outcome of Proceedings of AGM | |
| 28 Sep 2026 | Modern Diagnostic & Research Centre Ltd - 544673 - Closure of Trading Window | Intimation regarding of closure of trading window for the half year ending on 30.09.2026 |
Modern Diagnostic Research - Company Profile
Modern Diagnostic Research Management Structure
Modern Diagnostic Research management structure with salaries, total experience, and qualifications.
Modern Diagnostic Research Board of Directors
Modern Diagnostic Research Board of directors with salaries, total experience, and qualifications.
About the company - Business Profile
Modern Diagnostic & Research Centre Ltd. is a healthcare provider specializing in diagnostic and laboratory testing services. The company operates within the medical diagnostics industry, offering a range of pathology and imaging services to facilitate disease detection and health monitoring. Its business model is built on providing diagnostic accuracy and accessibility through a network of service centers and laboratories, catering to both individual patients and institutional clients.
Key Points
- Key Facts: Modern Diagnostic & Research Centre Ltd. operates as a key entity in the diagnostics sector. Its operations are centered around pathology and radiology services.
- Operations and Resources: The company utilizes a network of laboratories and collection centers. It employs medical professionals including pathologists and radiologists to interpret results.
- Market and Significance: The diagnostics industry is a critical component of the healthcare value chain, influencing a high percentage of clinical decisions. The company serves the growing demand for preventive healthcare and specialized diagnostic testing in India.
- Sustainability and Innovation: The company focuses on expanding its test menu to include advanced molecular diagnostics and genomic testing to keep pace with medical advancements.
- Business Model: The company follows an integrated diagnostic model, combining pathology (blood, urine, and tissue testing) with radiology (X-ray, Ultrasound, CT, and MRI scans). It leverages a hub-and-spoke model to optimize sample processing and service delivery.
- Revenue Breakdown: For the fiscal year ending March 31, 2025, revenue is primarily driven by diagnostic testing services. Geographically, operations are concentrated in specific regional clusters in India, with expansion efforts directed toward increasing its footprint in urban and semi-urban areas.
- Key Products and Services:
- Pathology: Routine and specialized biochemistry, hematology, immunology, and microbiology tests.
- Radiology and Imaging: Ultrasound, Digital X-ray, and more advanced imaging modalities.
- Wellness Packages: Comprehensive health check-up plans for various age groups and medical conditions.
- Strategic Initiatives: The company is focused on digital transformation, including the implementation of online report delivery and mobile application-based bookings to improve patient experience. Future outlook involves increasing the density of collection centers to improve market penetration.
Insufficient information for specific financial figures (revenue by segment/geography) and employee metrics as the exact annual report for Modern Diagnostic & Research Centre Ltd. was not fully detailed in the current search results.
References
